Technical Analysis for CRNX - Crinetics Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 46.81 5.36% 2.38
CRNX closed up 5.36 percent on Thursday, March 28, 2024, on 1.65 times normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Up 3 Days in a Row Strength 0.00%
Calm After Storm Range Contraction 5.36%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 7.93%
Calm After Storm Range Contraction 7.93%
Inside Day Range Contraction 7.93%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 8.56%
Calm After Storm Range Contraction 8.56%
Down 3 Days in a Row Weakness 8.56%

   Recent Intraday Alerts

Alert Time
Upper Bollinger Band Resistance about 20 hours ago
Up 1 ATR about 20 hours ago
60 Minute Opening Range Breakout about 23 hours ago
Up 5% about 23 hours ago
Up 3% about 23 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Crinetics Pharmaceuticals, Inc. Description

Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company. The Company is focused on the discovery and development of drugs to treat specialty endocrine diseases and endocrine-related tumors. It develops a pipeline of oral nonpeptide chemical entities that target peptide G protein coupled receptors (GPCRs) for the treatment of endocrine diseases. The Company’s lead product candidate is CRN00808 developed for the treatment of acromegaly. It also develops two other product candidates CRN02481 for hyperinsulinemia, and CRN01941 for the treatment of neuroendocrine tumors. CRN02481 and CRN01941 are both oral nonpeptide somastatin receptors that are in the pre-clinical stages of development. The company also conducts research programs on developing nonpeptide products for the treatment of Cushing’s disease.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Disease Organ Systems Pancreatic Cancer Insulin Endocrine System Stage Pharmaceutical Chemical Entities Neuroendocrine Tumors Acromegaly Neuroendocrine Tumor Endocrine Disease Endocrine Diseases Neuroendocrinology

Is CRNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 47.58
52 Week Low 15.5
Average Volume 781,060
200-Day Moving Average 29.34
50-Day Moving Average 39.74
20-Day Moving Average 42.82
10-Day Moving Average 43.45
Average True Range 2.46
RSI (14) 64.16
ADX 26.18
+DI 32.04
-DI 16.34
Chandelier Exit (Long, 3 ATRs) 40.21
Chandelier Exit (Short, 3 ATRs) 44.81
Upper Bollinger Bands 47.75
Lower Bollinger Band 37.89
Percent B (%b) 0.9
BandWidth 23.03
MACD Line 1.50
MACD Signal Line 1.23
MACD Histogram 0.2651
Fundamentals Value
Market Cap 3.13 Billion
Num Shares 66.8 Million
EPS -3.64
Price-to-Earnings (P/E) Ratio -12.86
Price-to-Sales 558.22
Price-to-Book 4.82
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 51.53
Resistance 3 (R3) 51.13 49.14 50.75
Resistance 2 (R2) 49.14 47.94 49.35 50.48
Resistance 1 (R1) 47.98 47.20 48.56 48.38 50.22
Pivot Point 45.99 45.99 46.29 46.20 45.99
Support 1 (S1) 44.83 44.79 45.41 45.24 43.40
Support 2 (S2) 42.84 44.05 43.05 43.14
Support 3 (S3) 41.68 42.84 42.87
Support 4 (S4) 42.09